Celltrion targets $3.46 bn in sales this year on biosimilars
Seoul, March 18 (IANS) Celltrion, a major South Korean biopharmaceutical firm, on Tuesday said it aims to achieve 5 trillion won ($3.46 billion) in sales this year, helped by an expanded biosimilar lineup. The annual target is 40.5 per cent higher than the record high of 3.56 trillion won it posted last year, Yonhap news […]
